These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18772576)

  • 21. Toxic epidermal necrolysis caused by acetaminophen featuring almost 100% skin detachment: Acetaminophen is associated with a risk of severe cutaneous adverse reactions.
    Watanabe H; Kamiyama T; Sasaki S; Kobayashi K; Fukuda K; Miyake Y; Aruga T; Sueki H
    J Dermatol; 2016 Mar; 43(3):321-4. PubMed ID: 26362011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review.
    Wong A; Malvestiti AA; Hafner Mde F
    Rev Assoc Med Bras (1992); 2016; 62(5):468-73. PubMed ID: 27656858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D; Zachariae C; Thomsen SF
    Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel complication of Flakka: Stevens-Johnson syndrome/Toxic epidermal necrolysis overlap.
    İlhan B; Doğan H; Şahin EA; Karslıoğlu N; Koçak Ö
    Am J Emerg Med; 2019 Mar; 37(3):562.e1-562.e3. PubMed ID: 30503281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role?
    Mawson AR; Eriator I; Karre S
    Med Sci Monit; 2015 Jan; 21():133-43. PubMed ID: 25579087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Kaufman DW; Kelly JP
    Br J Clin Pharmacol; 2001 Feb; 51(2):174-6. PubMed ID: 11259991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: a patient who excreted long tubes of dead intestinal epithelium.
    Sugimoto Y; Mizutani H; Sato T; Kawamura N; Ohkouchi K; Shimizu M
    J Dermatol; 1998 Aug; 25(8):533-8. PubMed ID: 9769600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients.
    Bastuji-Garin S; Zahedi M; Guillaume JC; Roujeau JC
    Age Ageing; 1993 Nov; 22(6):450-6. PubMed ID: 8310891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical mesalazine as a cause of Stevens-Johnson syndrome.
    Núñez Ortiz A; Trigo Salado C; de la Cruz Ramírez MD; Herrera Justiniano JM; Leo Carnerero E
    Rev Esp Enferm Dig; 2018 Nov; 110(11):736-738. PubMed ID: 29931986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
    Lee HY; Tey HL; Pang SM; Thirumoorthy T
    Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine.
    Carstens J; Wendelboe P; Søgaard H; Thestrup-Pedersen K
    Acta Derm Venereol; 1994 Sep; 74(5):391-2. PubMed ID: 7817681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ileal involvement in toxic epidermal necrolysis (Lyell syndrome).
    Michel P; Joly P; Ducrotte P; Hemet J; Leblanc I; Lauret P; Lerebours E; Colin R
    Dig Dis Sci; 1993 Oct; 38(10):1938-41. PubMed ID: 8404419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis.
    Khazaka M; Laverdière J; Bouchard A; Ferreira V; Mathieu A
    J Pharm Pract; 2021 Dec; 34(6):970-974. PubMed ID: 32588724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etoricoxib Induced Toxic Epidermal Necrolysis in a case of Systemic Lupus Erythematosus: A Case Report.
    Pandey A; Parajuli S; Dhungel A; Devkota R; Dongol A
    JNMA J Nepal Med Assoc; 2022 Sep; 60(253):811-814. PubMed ID: 36705131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.